• Something wrong with this record ?

Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction

Š. Horáčková, M. Plocková, K. Demnerová,

. 2017 ; 36 (3) : 682-690. [pub] 20171214

Language English Country England, Great Britain

Document type Journal Article, Review

An important feature of the intestinal microbiota, particularly in the case of administered probiotic microorganisms, is their resistance to conditions in the gastrointestinal tract, particularly tolerance to and growth in the presence of bile salts. Bacteria can use several defence mechanisms against bile, including special transport mechanisms, the synthesis of various types of surface proteins and fatty acids or the production of exopolysaccharides. The ability to enzymatically hydrolyse bile salts occurs in a variety of bacteria. Choloylglycine hydrolase (EC 3.5.1.24), a bile salt hydrolase, is a constitutive intracellular enzyme responsible for the hydrolysis of an amide bond between glycine or taurine and the steroid nucleus of bile acids. Its presence was demonstrated in specific microorganisms from several bacterial genera (Lactobacillus spp., Bifidobacterium spp., Clostridium spp., Bacteroides spp.). Occurrence and gene arrangement encoding this enzyme are highly variable in probiotic microorganisms. Bile salt hydrolase activity may provide the possibility to use the released amino acids by bacteria as sources of carbon and nitrogen, to facilitate detoxification of bile or to support the incorporation of cholesterol into the cell wall. Deconjugation of bile salts may be directly related to a lowering of serum cholesterol levels, from which conjugated bile salts are synthesized de novo. Furthermore, the ability of microorganisms to assimilate or to bind ingested cholesterol to the cell wall or to eliminate it by co-precipitation with released cholic acid was also documented. Some intestinal microflora produce cholesterol reductase that catalyses the conversion of cholesterol to insoluble coprostanol, which is subsequently excreted in faeces, thereby also reducing the amount of exogenous cholesterol.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012976
003      
CZ-PrNML
005      
20190405092639.0
007      
ta
008      
190405s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biotechadv.2017.12.005 $2 doi
035    __
$a (PubMed)29248683
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Horáčková, Šárka $u Department of Dairy, Fat and Cosmetics, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: sarka.horackova@vscht.cz.
245    10
$a Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction / $c Š. Horáčková, M. Plocková, K. Demnerová,
520    9_
$a An important feature of the intestinal microbiota, particularly in the case of administered probiotic microorganisms, is their resistance to conditions in the gastrointestinal tract, particularly tolerance to and growth in the presence of bile salts. Bacteria can use several defence mechanisms against bile, including special transport mechanisms, the synthesis of various types of surface proteins and fatty acids or the production of exopolysaccharides. The ability to enzymatically hydrolyse bile salts occurs in a variety of bacteria. Choloylglycine hydrolase (EC 3.5.1.24), a bile salt hydrolase, is a constitutive intracellular enzyme responsible for the hydrolysis of an amide bond between glycine or taurine and the steroid nucleus of bile acids. Its presence was demonstrated in specific microorganisms from several bacterial genera (Lactobacillus spp., Bifidobacterium spp., Clostridium spp., Bacteroides spp.). Occurrence and gene arrangement encoding this enzyme are highly variable in probiotic microorganisms. Bile salt hydrolase activity may provide the possibility to use the released amino acids by bacteria as sources of carbon and nitrogen, to facilitate detoxification of bile or to support the incorporation of cholesterol into the cell wall. Deconjugation of bile salts may be directly related to a lowering of serum cholesterol levels, from which conjugated bile salts are synthesized de novo. Furthermore, the ability of microorganisms to assimilate or to bind ingested cholesterol to the cell wall or to eliminate it by co-precipitation with released cholic acid was also documented. Some intestinal microflora produce cholesterol reductase that catalyses the conversion of cholesterol to insoluble coprostanol, which is subsequently excreted in faeces, thereby also reducing the amount of exogenous cholesterol.
650    _2
$a amidohydrolasy $x metabolismus $7 D000581
650    _2
$a Bifidobacterium $x fyziologie $7 D001644
650    _2
$a žlučové kyseliny a soli $x metabolismus $7 D001647
650    _2
$a buněčná stěna $x metabolismus $7 D002473
650    _2
$a cholesterol $x krev $7 D002784
650    _2
$a cytoplazma $7 D003593
650    _2
$a poškození DNA $7 D004249
650    _2
$a střevní mikroflóra $x fyziologie $7 D000069196
650    _2
$a lidé $7 D006801
650    _2
$a Lactobacillus $x fyziologie $7 D007778
650    _2
$a probiotika $x farmakologie $7 D019936
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Plocková, Milada $u Department of Dairy, Fat and Cosmetics, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: milada.plockova@vscht.cz.
700    1_
$a Demnerová, Kateřina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic. Electronic address: katerina.demnerova@vscht.cz.
773    0_
$w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 36, č. 3 (2017), s. 682-690
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29248683 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190405092649 $b ABA008
999    __
$a ok $b bmc $g 1392286 $s 1051281
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 36 $c 3 $d 682-690 $e 20171214 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...